Microwave ablation versus radiofrequency ablation for subcapsular hepatocellular carcinoma: a propensity score–matched studyHang Zheng, Qiang Zhu, Kaiwen Liu et al.|European Radiology|2022Cited by 46
RECIST 1.1 versus mRECIST for assessment of tumour response to molecular targeted therapies and disease outcomes in patients with hepatocellular carcinoma: a systematic review and meta-analysisHongli Yu, Qiang Zhu, Yuping Bai et al.|BMJ Open|2022Cited by 42
Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysisYang Yao, Qiang Zhu, Xu Tan et al.|International Journal of Hyperthermia|2021Cited by 27
Combined radiofrequency ablation or microwave ablation with transarterial chemoembolization can increase efficiency in intermediate-stage hepatocellular carcinoma without more complication: a systematic review and meta-analysisYang Yao, Qiang Zhu, Hongli Yu et al.|International Journal of Hyperthermia|2022Cited by 26
Gadobenate dimeglumine–enhanced biliary imaging from the hepatobiliary phase can predict progression in patients with liver cirrhosisChenxi Liu, Xinya Zhao, Yan Sun et al.|European Radiology|2021Cited by 22